Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 90

Results For "CHI"

5488 News Found

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region


Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
R&D | April 24, 2026

Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples

Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance


Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels
Packaging | April 24, 2026

Clariant boosts high-speed packaging efficiency with expanded continuous strip desiccant reels

Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control


Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
People | April 24, 2026

Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations


KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy
Hospitals | April 24, 2026

KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy

Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility


ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
Clinical Trials | April 24, 2026

ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma

The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack


Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide
Hospitals | April 23, 2026

Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide

The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions